NIH Issues New Resources for Implementing the NIH Policy for Data Management and Sharing

NIH continues to work with the research community to ensure we address resource needs associated with the NIH Data Management and Sharing Policy. Today we are releasing a new set of FAQs on questions we have heard over the past year, and we are also seeking public comment on a new resource for researchers that promotes responsible management and sharing of American Indian/Alaska Native (AI/AN) participant data.

To learn more about the NIH approach to implementing the DMS Policy and next steps, please see the latest “Under the Poliscope” blog post by Dr. Lyric Jorgenson: Gearing Up for 2023: Implementing the NIH Data Management and Sharing Policy

For questions, contact the NIH Office of Science Policy at SciencePolicy@od.nih.gov.  Also, you can follow us on Twitter: @NIH_OSP

Gearing Up for 2023: Implementing the NIH Data Management and Sharing Policy

Frequent readers of this blog will remember that back in October 2020, NIH issued its Data Management and Sharing (DMS) Policy to further our commitment to making the research we fund available to the public. Our strategic decision to make the effective date for the Policy approximately two years later led some to ask NIH “why wait so long?” while others asked “why not give us more time?” Fortunately, the answer to both these questions is the same. Our goal is to lead a cultural shift that makes data sharing the norm. The degree of that shift, for some, may vary.  For example, many data sharing policies are already in place and researchers currently sharing data will likely not need to significantly alter their approach. But prospective planning for how to share data (i.e., developing plans, requesting NIH funds) may be new for some. As such, it seemed reasonable that two years was the right balance of time to lay the groundwork  for implementation. Today I am excited to provide an update on what NIH is doing to make our data management and sharing efforts a success on the one-year mark prior to the Policy’s effective date.

Since the Policy’s release, NIH has continued its approach of meeting and seeking feedback from its stakeholders. For example, in April 2021, NIH supported a two-day National Academies workshop to share strategies for successful data management and sharing and identify areas of additional need for seamless policy implementation. Thanks to the success of this workshop, we were able to continue engaging the public on multiple related resources and issues, such as consent for data sharing, harmonizing the NIH Genomic Data Sharing Policy with the DMS Policy, and the discoverability of our data resources.  We also have been partnering with our colleagues in the NIH Office of Extramural Research to provide implementation updates at extramural-focused meetings such as last year’s Virtual Seminar.

As you may recall, when the DMS Policy was released, we asked the community what other types of information would be of value to help with implementation. Based on the feedback we received, we are releasing additional resources today and have plans for continuing to release more throughout 2022.

Today, NIH is:

Over the course of 2022, you can expect to hear more from us regarding resources, including:

  • Helpful tips for developing budgets in Plans describing data management and sharing
  • Updated information on principles for protecting research participant privacy and de-identification to help guide sharing of research participant data
  • Educational resources including webinars and potentially sample Plans
  • Plans for further harmonizing NIH’s data management and sharing expectations, particularly with reducing duplicative plan submissions

In addition to the above, during 2022 NIH will also continue providing supplemental funding for grantees to:

  • Improve the FAIR and Artificial Intelligence/Machine Learning-Readiness of their NIH-Supported Data
  • Align existing data repositories with FAIR and TRUST principles and evaluate usage, utility, and impact

This is definitely an exciting year for NIH, and we look forward to continuing our engagement with the stakeholder community throughout 2022. Make sure to stay tuned –there is plenty more to come as we work together to accelerate scientific discovery through effective data management and sharing.

Posted by Dr. Lyric Jorgenson, January 25, 2022

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric

Refreshing NIH’s Genomic Data Sharing Policy

We’ve all heard the ancient expression that “the only constant in life is change.” While this phrase was first spoken about 2500 years ago, it is a remarkably insightful way of describing the most important aspect of policymaking; being able to adapt to a changing landscape.

NIH strives to ensure our policies keep pace with the science we support, and as policy professionals we work hard to anticipate the future while developing meaningful policies capable of supporting the present.  Naturally, this is easier said than done.  Complicated issues rarely are resolved on the first go-round and scientific opportunity and community expectations evolve over time.  Nuance, flexibility, and community experience are all necessary ingredients in evaluating the impact of a policy and its future course.  An interesting case study to illustrate this point can be found in the 2014 NIH Genomic Data Sharing (GDS) Policy.

For those of you who have been in the game for a while, you will remember that the GDS Policy was born out of the successes of the 2007 NIH Genome-Wide Association Study Policy.  In the roughly seven years between the release of the GWAS Policy and the formulation of the GDS Policy, much had changed.  Genome sequencing burgeoned and repositories for accepting and sharing genomic data proliferated. Additionally, the intrinsic value of one’s genome became increasingly apparent, and more protections were afforded through two landmark laws (the Genetic Information Non-Discrimination Act and the Affordable Care Act). When NIH looked at the impact of the GWAS policy, we saw substantial productivity as an important result.  At that point we began asking ourselves “how do we leverage these results to meaningfully improve health?” From there, the GDS Policy was born.

Now in the seven years since the GDS Policy has been issued, it has proven remarkably resilient in evolving with the science.  The Policy has kept pace with the increase in cloud computing, the emergence of novel methods to reduce the burden associated with accessing human genomic data, and a reassessment of the risks and benefits of sharing genomic summary results.  With that said, even the best policies can only accommodate a rapidly changing field so much through clarifying guidance documents.  The framework of the GDS Policy is continually tested by new trends in the field.

Some updates to the GDS Policy are common sense. For instance, the NIH Data Management and Sharing Policy, due to take effect in January 2023, necessitates consolidating and simplifying NIH’s data sharing expectations to minimize the burden of the compliance.  However, some are more complex. For instance, the growing demand to investigate the social determinants of health may benefit from access to data elements that NIH has not historically permitted to be submitted and shared through NIH genomic data repositories.  Additionally, new technology for preserving participant privacy while facilitating records linkage may open the possibility of matching participants’ data from genomic studies with other studies or even non-research data.

What does this all mean for the future?  This is where YOU come in.  Today, NIH released a “Request for Information on Proposed Updates and Long-Term Considerations for the NIH Genomic Data Sharing Policy.”  This is your opportunity to help us shape the future of the GDS Policy.  Stakeholder input is the key to ensuring that NIH strikes the right balance when updating the GDS Policy.  Comments will be accepted until February 28, 2022.  The full RFI and instructions on how to comment may be found here.  I am very excited to hear your thoughts on how we can best serve the needs of the research community!

Dr. Lyric Jorgenson is the Acting Associate Director for Science Policy and Acting Director of the NIH Office of Science Policy.  While the Under the Poliscope blog is under new authorship, it will continue to be a direct link between OSP and our stakeholders.  Please feel free to comment below on how we are doing.  Also, to learn more about Lyric, please visit here.

Posted by Dr. Lyric Jorgenson, December 1, 2021

Lyric Jorgenson, PhD
NIH Associate Director for Science Policy
About Lyric

Parenting in a Time of COVID

Next week marks the one-year anniversary of NIH shifting to maximum telework in response to the COVID-19 pandemic. Like employers and employees across the country, overnight we needed to adapt our entire enterprise and reinvent our jobs in the virtual workplace. Coincidentally, next week is also when with a deep breath and a big hug, I send my six year old back to school in person, masked up and excited to meet his 1st grade teacher in person for the first time. So it seems like a good time to reflect on what the past year has been like, juggling the demands of serving in the leadership of a government agency square in the middle of COVID response with the needs of two young children during this nationwide experiment in virtual schooling.

Over the past year, I have gotten expert at the hand-over-the-mouth side conversations with my kids while muted on videoconference. There are good days and there are bad days. Like when my already prone-to-anxiety fifth grader gets hysterical because there are technology glitches and is panicked he’s missed something. Or when my first grader breaks down into tears because he’s had to sit in front of a computer for hours and is confused by something being asked of him. Inevitably, these moments occur when I’m in the middle of a critical meeting. I’ve accidentally come off mute while in the middle of alternately yelling at and bribing my children to behave so I can just pay attention to this conversation. I long for five minutes to just pay sole attention to the work I am doing and not have to think about snack time or lunch options or whether trombone is starting to whether a Chromebook is charged. I struggle to feel smart and competent as either a mother or as a professional when the unrelenting demands of one are constantly competing with the other.

Much to the entertainment of my colleagues, I have found my six year old does best when I am working nearby, which means he is constantly in the background of my WebEx or Zoom – fidgeting, coloring, doing jumping jacks – as I try to provide intelligent advice on agency policy with a song about counting frogs in one ear. I have been caught frozen in moments of indecision, as my children come running up in hysterical tears for help with one thing or another, but I have an upcoming item on the agenda to speak to. And that’s the curated account – not delving into the darker moments when I break down in tears or lose my temper because I reached the limits of my emotional wherewithal and snap at my kids in a voice I barely recognize as my own. Or those days when I have trouble caring about what’s going on at work or just turn my children over to electronic devices for a moment of peace. I worry all the time that having my children continually visible in my workspace, demonstrating my constant state of distraction, will cause my (primarily older and male) colleagues to take me less seriously.

The media has offered extensive coverage of how truly difficult this balancing act has been, the disproportionate effect it is having on women or individuals whose jobs do not support telework, such as healthcare workers or front-line service providers, and the agonizing choice faced by many parents struggling with impossible dilemmas of keeping themselves or their loved ones safe from a deadly disease while trying to do what’s best for their child’s well-being and education. The wrench the pandemic has thrown into the everyday tension of work-life balance just doesn’t affect women, of course. In my own household, my husband has taken on more childcare responsibilities than ever, as the pandemic has increased my workload, and a recent Pew study seems to indicate this is happening all over the country1. But evidence has long shown that women bear a disproportionate burden of household and dependent care responsibilities2, and the early data on the negative impact of the pandemic on the productivity of women in science is truly alarming3. There is recognition across the biomedical enterprise that the long-term impact of the pandemic could entail a devastating setback for women and others with dependent care responsibilities, and there are a lot of discussions of strategies to minimize that risk.

In a world currently experiencing staggering loss of life and economic misfortune due to COVID-19, my challenges pale by comparison. My family has been able to stay safe, we are healthy, we are employed… and yet still it is a struggle. Even as it feels like hope is on the horizon, in the form of vaccine and falling hospitalization rates and opening of schools, we must recognize not just the toll the past year has taken on working women and parents, but also not lose sight of the bright light the pandemic has cast on this balancing act. The challenge of balancing work and caregiving doesn’t go away just because it isn’t visible on Zoom. We need to create an environment that feels safe for caregivers, particularly women, to talk about their real-world dilemmas and ask for help or just feel empathy from their peers, without feeling like revealing this diminishes us as professionals. I thought long and hard about writing such a personal blog post, but I worry that by not talking candidly and honestly about how difficult juggling this all is, I am serving as a bad role model. The working mom dilemma exists in the best of time, as author Amy Westfield describes it “We expect women to work like they don’t have children, and raise children as if they don’t work.”

I am not going to end this blog post with a pithy solution that diminishes the complexity of the problem or suggests I personally have this all figured out. The next few years will undoubtedly be dominated by a “lessons learned” conversation about COVID 19, and I plan to use my seat at the table of scientific leadership to make sure we haven’t squandered a crisis for women in science.  I hope other leaders, both men and women, will do the same.

1 https://www.pewresearch.org/fact-tank/2020/10/22/fewer-mothers-and-fathers-in-u-s-are-working-due-to-covid-19-downturn-those-at-work-have-cut-hours/

2 https://www.forbes.com/sites/maggiegermano/2019/03/27/women-are-working-more-than-ever-but-they-still-take-on-most-household-responsibilities/?sh=71bbae5e52e9

3 https://www.scientificamerican.com/article/women-in-science-may-suffer-lasting-career-damage-from-covid-19/

Posted by Dr. Carrie D. Wolinetz, March 8, 2021